MARATTO

article · Parasitologists United Journal

Changes in histopathological phenotypes of Schistosomaassociated urinary bladder cancer in Sohag, Egypt

2024Open accessSohag University

Abstract

Background: Squamous cell carcinoma is the most common type in Egyptian bilharzial bladder. However,there is a proven changing pattern of Schistosoma-associated bladder cancer (SA-BC) that needs to beinvestigated.Objective: To assess the patterns (age, incidence, and histopathological types) of SA-BC in Sohag, Egypt.Material and Methods: This descriptive retrospective study included 152 patients histologicallyconfirmed urinary BC diagnosed at the Pathology Department of Sohag University Hospital during 4 years,from January 2019 to December 2022. Data including age, sex, residence, and histopathological type wereretrieved from the records of Pathology Department.Results: Patients’ age ranged from 35-79 years with a mean of 61.2±9.1 years, and male to female ratiowas 4.6:1. Transitional cell carcinoma (TCC) was the most common histological type (80.9%), followed bysquamous cell carcinoma (SCC) (12.5%), and TCC with squamous differentiation (6.6%). Schistosoma eggswere histologically confirmed in 39.5% of cancer cases; 76.7% were TCC, 21.7% were SCC and only 1.6%was TCC with squamous differentiation. All SA-BC were male with mean age of 59.8±7.5. At the time ofdiagnosis, 96.7% of SA-BC cases were bladder muscle invasive and 91.7% were of high-grade nature notsignificantly different from cases with non-Schistosome associated BC (NSA-BC).Conclusion: The histopathological patterns of SA-BC have changed in Egypt over the past decade andmost cases were associated with TCC.

Research topics

  • Bladder and Urothelial Cancer Treatments
  • Amoebic Infections and Treatments
  • Parasites and Host Interactions

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21608/puj.2024.265820.1236

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.